EE03954B1 - Toimeaine pärsitud vabanemisega karbamasepiini ravimvormi valmistamise meetod - Google Patents

Toimeaine pärsitud vabanemisega karbamasepiini ravimvormi valmistamise meetod

Info

Publication number
EE03954B1
EE03954B1 EE9600202A EE9600202A EE03954B1 EE 03954 B1 EE03954 B1 EE 03954B1 EE 9600202 A EE9600202 A EE 9600202A EE 9600202 A EE9600202 A EE 9600202A EE 03954 B1 EE03954 B1 EE 03954B1
Authority
EE
Estonia
Prior art keywords
carbamazepine
pct
preparation
dosage form
sustained release
Prior art date
Application number
EE9600202A
Other languages
English (en)
Estonian (et)
Other versions
EE9600202A (et
Inventor
Landgraf Karl-Friedrich
Reiss Sabine
Schubert Eberhard
Original Assignee
Arzneimittelwerk Dresden Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arzneimittelwerk Dresden Gmbh filed Critical Arzneimittelwerk Dresden Gmbh
Publication of EE9600202A publication Critical patent/EE9600202A/xx
Publication of EE03954B1 publication Critical patent/EE03954B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
EE9600202A 1994-07-01 1995-06-22 Toimeaine pärsitud vabanemisega karbamasepiini ravimvormi valmistamise meetod EE03954B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19944423078 DE4423078B4 (de) 1994-07-01 1994-07-01 Verfahren zur Herstellung einer Carbamazepin-Arzneiform mit verzögerter Wirkstofffreisetzung
PCT/DE1995/000805 WO1996001112A1 (de) 1994-07-01 1995-06-22 Carbamazepin-arzneiform mit verzögerter wirkstofffreisetzung

Publications (2)

Publication Number Publication Date
EE9600202A EE9600202A (et) 1997-06-16
EE03954B1 true EE03954B1 (et) 2003-02-17

Family

ID=6522000

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9600202A EE03954B1 (et) 1994-07-01 1995-06-22 Toimeaine pärsitud vabanemisega karbamasepiini ravimvormi valmistamise meetod

Country Status (23)

Country Link
US (1) US5888545A (cs)
EP (1) EP0768882B1 (cs)
JP (1) JPH10502358A (cs)
KR (1) KR100344477B1 (cs)
CN (1) CN1101191C (cs)
AT (1) ATE169818T1 (cs)
BG (1) BG62794B1 (cs)
BR (1) BR9508202A (cs)
CA (1) CA2194216A1 (cs)
CZ (1) CZ288028B6 (cs)
DE (2) DE4423078B4 (cs)
DK (1) DK0768882T3 (cs)
EE (1) EE03954B1 (cs)
ES (1) ES2122630T3 (cs)
GE (1) GEP19991819B (cs)
HU (1) HU221486B (cs)
LT (1) LT4251B (cs)
LV (1) LV11820B (cs)
PL (1) PL180979B1 (cs)
RU (1) RU2141825C1 (cs)
SK (1) SK282303B6 (cs)
UA (1) UA32598C2 (cs)
WO (1) WO1996001112A1 (cs)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6162466A (en) * 1999-04-15 2000-12-19 Taro Pharmaceutical Industries Ltd. Sustained release formulation of carbamazepine
US20060275367A1 (en) * 2005-04-25 2006-12-07 Shubha Chungi Extended release formulations
CN101252932B (zh) * 2005-09-09 2012-10-03 安吉利尼莱博法姆有限责任公司 用于一天给药一次的曲唑酮组合物
US20070160960A1 (en) * 2005-10-21 2007-07-12 Laser Shot, Inc. System and method for calculating a projectile impact coordinates
FR2940910A1 (fr) * 2009-01-09 2010-07-16 Vetoquinol Sa Nouveau comprime a base de s-adenosyl-methionine
CN105997916A (zh) * 2016-07-19 2016-10-12 南京正宽医药科技有限公司 一种卡马西平片及其制备方法
CN108125922A (zh) * 2018-01-14 2018-06-08 上海安必生制药技术有限公司 一种卡马西平口服缓释制剂及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK150008C (da) * 1981-11-20 1987-05-25 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
SE8203953D0 (sv) * 1982-06-24 1982-06-24 Astra Laekemedel Ab Pharmaceutical mixture
DK151608C (da) * 1982-08-13 1988-06-20 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat med kontrolleret afgivelse
CH668187A5 (de) * 1986-08-07 1988-12-15 Ciba Geigy Ag Therapeutisches system mit systemischer wirkung.
IL86211A (en) * 1987-05-04 1992-03-29 Ciba Geigy Ag Oral forms of administration for carbamazepine in the forms of stable aqueous suspension with delayed release and their preparation
US5326572A (en) * 1989-03-23 1994-07-05 Fmc Corporation Freeze-dried polymer dispersions and the use thereof in preparing sustained-release pharmaceutical compositions

Also Published As

Publication number Publication date
LV11820B (en) 1997-12-20
KR100344477B1 (ko) 2002-11-23
DE59503283D1 (de) 1998-09-24
EP0768882A1 (de) 1997-04-23
SK282303B6 (sk) 2002-01-07
GEP19991819B (en) 1999-11-05
HU221486B (en) 2002-10-28
CZ288028B6 (cs) 2001-04-11
BG101080A (en) 1997-08-29
DE4423078A1 (de) 1996-01-04
ES2122630T3 (es) 1998-12-16
PL180979B1 (pl) 2001-05-31
CZ382696A3 (en) 1997-05-14
KR970703774A (ko) 1997-08-09
DE4423078B4 (de) 2005-01-13
HUT76821A (en) 1997-11-28
EE9600202A (et) 1997-06-16
JPH10502358A (ja) 1998-03-03
SK164696A3 (en) 1997-06-04
RU2141825C1 (ru) 1999-11-27
WO1996001112A1 (de) 1996-01-18
LT4251B (en) 1997-12-29
LV11820A (lv) 1997-08-20
CA2194216A1 (en) 1996-01-18
UA32598C2 (uk) 2001-02-15
ATE169818T1 (de) 1998-09-15
CN1153475A (zh) 1997-07-02
DK0768882T3 (da) 1999-05-25
PL317996A1 (en) 1997-05-12
BR9508202A (pt) 1997-11-11
BG62794B1 (bg) 2000-08-31
CN1101191C (zh) 2003-02-12
LT97012A (en) 1997-08-25
HU9603565D0 (en) 1997-02-28
US5888545A (en) 1999-03-30
EP0768882B1 (de) 1998-08-19

Similar Documents

Publication Publication Date Title
ATE198152T1 (de) Oral anzuwendende arzneizubereitung mit verzögerter wirkstoffabgabe
DE69100991T2 (de) Pharmazeutische formulierungen.
GR1002564B (el) Στερεα απο του στοματος χορηγουμενη φαρμακευτικη μορφη δοσιμετρησεως προγραμματισμενου ρυθμου απελευθερωσεως.
EP0382077A3 (de) Diarylsubstituierte heterocyclische Verbindung, ihre Herstellung und Arzneimittel und Kosmetika daraus
KR960700061A (ko) 니코틴 의존상태 치료를 위한 약리학적 제형 (pharmaceutical composition for treating nicotine dependence)
ES2158101T3 (es) Formulaciones farmaceuticas efervescentes que contienen microcapsulas biodegradables de liberacion controlada.
NO992944L (no) Virkestoffbµrer for avgivelse av apomorfin i munnhulen
IT8220758A1 (it) Prodotti farmaceutici in forma-ritardo e procedimento per ottenerli
RS50298B (sr) Direktno kompresibilna matrica za kontrolisano oslobađanje pojedinačnih dnevnih doza klaritromicina
DK15388A (da) Fremgangsmaade til fremstilling af et forsinkelsesprodukt indeholdende diltiazem med en saerlig daglig dosering
EE03954B1 (et) Toimeaine pärsitud vabanemisega karbamasepiini ravimvormi valmistamise meetod
GR890100833A (en) Process for the preparation of a compound with gastric inhibitopy effect
ATE206042T1 (de) Verfahren zur herstellung von niedrigdosierten arzneimitteln
SE9501671D0 (sv) Method and composition for prevention of posterior capsule opacification
GR3024854T3 (en) Drugs for preventing the development of tolerance during treatment with benzodiazepine-receptor-binding substances.
ATE85218T1 (de) Oral anzuwendende arzneiform zur einmal taeglichen behandlung der hypertonie mit diltiazemhydrochlorid.
ATE212840T1 (de) Oral anzuwendende feste arzneizubereitungen mit modulierter wirkstoffabgabe enthaltend nicorandil und verfahren zu deren herstellung
JPS54126722A (en) Slow release antibiotic tablet
DE69416034T2 (de) Pharmazeutische Zubereitung zur rektalen Verabreichung von pharmakologisch wirksamen Verbindungen
MY102368A (en) Solid sustained-release composition
TH20304EX (th) สูตรปลดปล่อยที่ควบคุมซึ่งมีทรามาดอล
TH21515A (th) การปลดปล่อยซิซาไพรด์นาน

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20091231

KB4A Valid patent at the end of a year

Effective date: 20101231